Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal CancerJin Li(Sichuan University), Weiguo Su(Tamedia (Switzerland))JAMAJune 26, 201810.1001/jama.2018.7855Cited by 396SaveCiteExport RISWatch citationsRelated PapersPhase Ia/Ib Study of the Selective MET Inhibitor, Savolitinib, in Patients with Advanced Solid Tumors: 
Safety, Efficacy, and Biomarkers|The Oncologist|2022|15